Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, Andreas, Grund, Stefanie, Mui, Barbara L, Hope, Michael J, Baumhof, Patrick, Fotin-Mleczek, Mariola, Schlake, Thomas·2015·Molecular Therapy
DOI 10.1038/mt.2015.103

Cited by (514)

Items 501–514 of 514

  1. A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine
    Giovana Ciacci Zanella, Marissa Vincent, Leo Flores, Ethan K. Aljets, Rodrigo C. Paiva, Alexey Markin, Blake Inderski, Garima Dwivedi, Drew Weissman, Meghan Wymore Brand et al. · 2026 · Journal of Virology
  2. Post-Marketing Safety of mRNA Vaccines: A Real-World Study Integrating Literature Case Reports and Vaccine Adverse Event Reporting System
    Bagejiang Tulisibaike, Tian-Yi Yang, W Gu, Huan Liu, Ying Wang, Jin-Qi Yang, Tong Wang, Si-Miao Ding, Rong-Xue Cai, Ying Wang et al. · 2026 · Vaccines
  3. Messenger RNA-encoded reporters for monitoring cellular stress and bioenergetics
    Karen Kai-Lin Hwang, Qi Fang, Carine Nizard, Anne‐Laure Bulteau, Knut Woltjen · 2026 · Scientific Reports
  4. Programming the immunological properties of mRNA vaccines for cancer
    Annette Wu, Seong Dong Jeong, Benjamin R. Schrank, Betty Y.S. Kim, Padmanee Sharma, Wen Jiang · 2026 · Nature reviews. Immunology
  5. Computational design and immunoinformatic validation of a multistage mRNA vaccine candidate against Mycobacterium tuberculosis
    Manika Sharma, Parul Bhatt, Dr M K Singh, Kiran Bharat Lokhande, Shailendra Asthana, Monika Sharma, Sadhna Sharma · 2026 · In Silico Pharmacology
  6. Quantum AI in mRNA Vaccine Development
    Noha Fakhoury, Don Roosan · 2026 · Springer eBooks
  7. Possible Mechanisms of mRNA-LNP Degradation: A Comprehensive Review
    MD Faizul Hussain Khan, Tahsina Islam, Abhishek Mishra, Amine Kamen · 2026 · Vaccines
  8. Design and Evaluation of the Immunogenicity of a Candidate mRNA Vaccine Against Seasonal Influenza
    Sergey V. Sharabrin, D. N. Kisakov, Victoria R. Litvinova, А. П. Рудометов, Alexander A. Ilyichev and; Larisa I. Karpenko, Larisa I. Karpenko · 2026 · Pharmaceutical science.
  9. Applications and future perspectives of mathematical biology
    Fatma Bozkurt · 2026 · Elsevier eBooks
  10. Innate immune responses underlying local and systemic adverse reactions to mRNA–lipid nanoparticle vaccines
    Tomohiro Takano, Takayuki Matsumura, Yoshimasa Takahashi · 2026 · International Immunology
  11. In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities
    Natacha Jugniot · 2026 · European Journal of Medicinal Chemistry
  12. Experimental evidence and consequences of biomolecular corona formation on inhaled mRNA lipid nanoparticles
    Mélina Guérin, Asia Saorin, Alberto Martinez‐Serra · 2026 · Health Nanotechnology
  13. Next-generation CAR therapies enabled by mRNA engineering and delivery
    Qinghao Zhao, Qinqin Wen, Peizhen Pu, Caili Xu, Qinchao Hu, Zhuoran Zhou, Xianxin Hua, Xuyao Zhang · 2026 · Acta Pharmaceutica Sinica B
  14. mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers
    Michele Ghidini, Federica Novazzi, Nerina Denaro, Angelica Petrillo, Margherita Ratti, Massimiliano Salati, Roberta Malvaso, Lorenza Di Marco, Alessandro Parisi, Jens Claus Hahne · 2026 · Cells